Sanofi (SAN)

Basic

  • Market Cap

    €108.31B

  • EV

    €121.66B

  • Shares Out

    1,253.88M

  • Revenue

    €45.7B

  • Employees

    91,573

Margins

  • Gross

    69.54%

  • EBITDA

    29.16%

  • Operating

    21.99%

  • Pre-Tax

    24.87%

  • Net

    19.84%

  • FCF

    19.65%

Returns (5Yr Avg)

  • ROA

    4.34%

  • ROE

    10.62%

  • ROCE

    8.38%

  • ROIC

    7.07%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €105.4

  • P/E

  • EV/Sales

  • EV/EBITDA

  • EV/FCF

Per Share

  • Rev

    €36.51

  • Earnings (Dil)

    €7.21

  • FCF

    €7.1

  • Book Value

    €58.03

Growth (CAGR)

  • Rev 3Yr

    6.67%

  • Rev 5Yr

    5.29%

  • Rev 10Yr

    3.18%

  • Dil EPS 3Yr

    -6.78%

  • Dil EPS 5Yr

    17.6%

  • Dil EPS 10Yr

    11.87%

  • Rev Fwd 2Yr

    4.51%

  • EBITDA Fwd 2Yr

    -1.09%

  • EPS Fwd 2Yr

    -1.07%

  • EPS LT Growth Est

    6.46%

Dividends

  • Yield

  • Payout

    53.24%

  • DPS

    €3.56

  • DPS Growth 3Yr

    4.16%

  • DPS Growth 5Yr

    3.28%

  • DPS Growth 10Yr

    2.54%

  • DPS Growth Fwd 2Yr

    3.01%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM

Revenues

34,463.0

36,126.0

36,041.0

37,761.0

42,997.0

42,876.0

Other Revenues, Total

1,214.0

1,505.0

1,328.0

1,414.0

2,392.0

2,823.0

Total Revenues

35,677.0

37,631.0

37,369.0

39,175.0

45,389.0

45,699.0

Total Revenues % Chg.

-1.5%

5.5%

-0.7%

4.8%

15.9%

3.0%

Cost of Goods Sold, Total

11,321.0

11,976.0

12,106.0

12,251.0

13,692.0

13,919.0

Gross Profit

24,356.0

25,655.0

25,263.0

26,924.0

31,697.0

31,780.0

Selling General & Admin Expenses, Total

9,934.0

9,967.0

9,448.0

9,599.0

10,539.0

10,703.0

R&D Expenses

5,894.0

6,020.0

5,530.0

5,692.0

6,706.0

6,679.0

Amortization of Goodwill and Intangible Assets

2,170.0

2,146.0

1,681.0

1,580.0

1,827.0

1,828.0

Other Operating Expenses

334.0

720.0

1,025.0

1,488.0

1,587.0

2,522.0

Other Operating Expenses, Total

18,332.0

18,853.0

17,684.0

18,359.0

20,659.0

21,732.0

Operating Income

6,024.0

6,802.0

7,579.0

8,565.0

11,038.0

10,048.0

Interest Expense, Total

-471.0

-544.0

-459.0

-362.0

-394.0

-790.0

Interest And Investment Income

72.0

91.0

37.0

3.0

173.0

516.0

Net Interest Expenses

-399.0

-453.0

-422.0

-359.0

-221.0

-274.0

Income (Loss) On Equity Invest.

499.0

255.0

359.0

39.0

68.0

16.0

Currency Exchange Gains (Loss)

6.0

1.0

-6.0

2.0

-4.0

-4.0

Other Non Operating Income (Expenses)

134.0

236.0

144.0

70.0

37.0

37.0

EBT, Excl. Unusual Items

6,264.0

6,841.0

7,654.0

8,317.0

10,918.0

9,823.0

Restructuring Charges

-1,480.0

-1,088.0

-1,089.0

-820.0

-1,336.0

-976.0

Merger & Related Restructuring Charges

-170.0

-3.0

-53.0

-4.0

-3.0

-3.0

Gain (Loss) On Sale Of Investments

63.0

7,388.0

3.0

1.0

1.0

Gain (Loss) On Sale Of Assets

326.0

296.0

443.0

418.0

655.0

655.0

Asset Writedown

-718.0

-3,604.0

-330.0

-192.0

228.0

1,882.0

Legal Settlements

327.0

Other Unusual Items

619.0

238.0

124.0

115.0

27.0

-17.0

EBT, Incl. Unusual Items

4,904.0

3,007.0

14,137.0

7,837.0

10,490.0

11,365.0

Income Tax Expense

481.0

121.0

1,807.0

1,558.0

2,006.0

2,203.0

Earnings From Continuing Operations

4,423.0

2,886.0

12,330.0

6,279.0

8,484.0

9,162.0

Earnings Of Discontinued Operations

-13.0

-101.0

Minority Interest

-104.0

-31.0

-36.0

-56.0

-113.0

-96.0

Net Income

4,306.0

2,754.0

12,294.0

6,223.0

8,371.0

9,066.0

Net Income to Common Incl Extra Items

4,306.0

2,754.0

12,294.0

6,223.0

8,371.0

9,066.0

Net Income to Common Excl. Extra Items

4,319.0

2,855.0

12,294.0

6,223.0

8,371.0

9,066.0

Total Shares Outstanding

1,245.5

1,253.8

1,250.7

1,252.5

1,252.6

1,253.2

Weighted Avg. Shares Outstanding

1,247.1

1,249.9

1,253.6

1,252.5

1,251.9

1,251.8

Weighted Avg. Shares Outstanding Dil

1,255.2

1,257.1

1,260.1

1,257.9

1,256.9

1,256.8

EPS

3.5

2.2

9.8

5.0

6.7

7.2

EPS Diluted

3.4

2.2

9.8

5.0

6.7

7.2

EBITDA

9,363.0

10,113.0

10,466.0

11,251.0

14,062.0

13,325.5